Package 55150-342-25

{"route": ["INTRAVENOUS"], "spl_id": "efd433ac-b10b-48e4-bda2-4d0395062d34", "openfda": {"upc": ["0355150342013", "0355150343010", "0355150342051"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["def3b9ba-523d-4b83-a80d-fa6f362e111c"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-342-01", "marketing_start_date": "20200706"}, {"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-05)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-342-05", "marketing_start_date": "20200706"}, {"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (55150-342-25)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55150-342-25", "marketing_start_date": "20200706"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "55150-342_efd433ac-b10b-48e4-bda2-4d0395062d34", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "55150-342", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA212965", "marketing_category": "ANDA", "marketing_start_date": "20200706", "listing_expiration_date": "20261231"}